Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

temamide 100
Connect with this vendor - Learn about this product

TELAMIDE 100 - Temozolomide Capsules IP 100 mg

TELAMIDE 100

Composition: Temozolomide Capsules IP 100 mg

Dosage Form:  Capsules

Packing: 5 Capsules

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country of Origin: India

Similar to 

Pharmaceuticals Product

Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. Temozolomide capsule is indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.